Skip to main content

Table 3 Seroconversion in prefrail and frail subjects, and in all study subjects 4 weeks after influenza vaccination

From: Influenza vaccine response in community-dwelling German prefrail and frail individuals

Vaccine strain

Prefrail (n = 48) n/N (%)

Frail (n = 25) n/N (%)

All (n = 73) n/N (%)

p value (prefrail vs. frail)

A/California/7/2009 (H1N1)

23/48 (47.9)

13/25 (52.0)

36/73 (49.3)

0.93

A/Texas/50/2012 (H3N2)

15/48 (31.3)

7/25 (28.0)

22/73 (30.1)

0.99

B/Massachusetts/2/2012

8/48 (16.7)

4/25 (16.0)

12/73 (16.4)

1.00

  1. Data are numbers of seroconverted (n)/total (N) and % of seroconverted subjects in parentheses